BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Integrated DNA Technologies and Aldevron Partner to Provide CRISPR Components to Therapy Developers

Leading CRISPR gene editing companies Integrated DNA Technologies and Aldevron inked a new global distribution agreement to...

September 19, 2023 | News

Agilent & NCCS Collaborate to Advance Genomic Profiling in Asian Cancers

The scope of the agreement includes the supply of an Agilent Magnis Next-Generation Sequencing (NGS) Preparation System to help investigate details specifi...

September 19, 2023 | News

MGI Collaborates with National Cancer Centre Singapore for Asian Cancer Genomic Profiling

"We are excited to work with NCCS to uncover the unique molecular genomic composition of cancers prevalent in Asia by providing our DNBSEQ-G400 s...

September 18, 2023 | News

Porton Advanced and BRL Medicine Partner to Fast-Track Gene and Cell Therapy Commercialization

BRL Medicine, with its strong gene editing technology, robust R&D capabilities, and prospective pipelines, has been devoted to the realm of CGT for yea...

September 15, 2023 | News

Singleron Unveils AccuraCode® TCR Kit for Streamlined T-Cell Profiling

The product is built upon Singleron's molecular barcoding technology, enabling multiplexing of 96 or 384 samples in a single library construction reaction....

September 14, 2023 | News

Metabolon Debuts Stress Discovery Panel for Biomarker Detection

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, diagnostic, therapeutic development, and preci...

September 13, 2023 | News

Waters Introduces Simplified Solutions for Biologic Drug Analysis

Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and...

September 13, 2023 | News

MGI Launches the DCS Lab Initiative to Expand Global Omics Access and Capabilities

"We are proud that through the DCS Lab Initiative, MGI technology and innovation will empower researchers and scientists in achieving their next breakthrou...

September 12, 2023 | News

Lonza Upgrades MODA-ES® Module for Enhanced Electronic Batch Record Execution

The MODA-ES® Module v4.0 is an electronic batch record solution that helps pharmaceutical customers to expedite batch release by minimizing p...

September 11, 2023 | News

Mabwell and WuXi XDC Forge Long-Term ADC Partnership for Biologics Expansion

Mabwell has had multiple innovative products in clinical studies or preclinical research by their world-leading ADC technology platforms and CMC developmen...

September 11, 2023 | News

Verily and Kyverna Collaborate to Advance Cell Therapy for Autoimmune Diseases

Verily, an Alphabet precision health technology company, and Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company engineering a new clas...

September 08, 2023 | News

Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment

The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...

September 07, 2023 | News

Gloria Biosciences' Zimberelimab Approved in China for Recurrent Cervical Cancer

Guangzhou Gloria Biosciences ("GloriaBio"), a commercial stage biopharmaceutical company focusing on the discovery, development and commercialization of bi...

September 07, 2023 | News

Biocon Biologics Expands Global Presence, Completes Viatris Biosimilars Integration in North America Ahead of Schedule.

To further strengthen its leadership position in the global biosimilars industry and provide complete end-to-end capabilities to patients and customers, Bi...

September 07, 2023 | News

Stay Connected